A histone H3.3K36M mutation in mice causes an imbalance of histone modifications and defects in chondrocyte differentiation
Histone lysine-to-methionine (K-to-M) mutations have been identified as driver mutations in human cancers. Interestingly, these ‘oncohistone’ mutations inhibit the activity of histone methyltransferases. Therefore, they can potentially be used as versatile tools to investigate the roles of histone m...
Main Authors: | Shusaku Abe, Hiroaki Nagatomo, Hiroyuki Sasaki, Takashi Ishiuchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-10-01
|
Series: | Epigenetics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15592294.2020.1841873 |
Similar Items
-
Histone variant H3.3 and its future prospects in cancer clinic
by: Divya Reddy, et al.
Published: (2017-01-01) -
Histone H2B Mutations in Cancer
by: Yi Ching Esther Wan, et al.
Published: (2021-06-01) -
Nuclear envelope, chromatin organizers, histones, and DNA: The many achilles heels exploited across cancers
by: A. K. Balaji, et al.
Published: (2022-12-01) -
Histone Methylases and Demethylases Regulating Antagonistic Methyl Marks: Changes Occurring in Cancer
by: Joyce Taylor-Papadimitriou, et al.
Published: (2022-03-01) -
Structural basis for histone variant H3tK27me3 recognition by PHF1 and PHF19
by: Cheng Dong, et al.
Published: (2020-09-01)